Heart clot study asks: when can you safely stop blood thinners?
NCT ID NCT07246005
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study looks at people with a blood clot in the heart (left ventricular thrombus) who have been on blood thinners for at least 3 months. Half will stop their medication and half will continue, to see which approach is safer. The goal is to find the best treatment duration and to test whether a larger study is possible.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- rivaroxaban, apixaban, or warfarin (blood thinners)
- What this could lead to
- If successful, this could help doctors know the safest time to stop blood thinners in people with left ventricular thrombus, reducing bleeding risk while preventing strokes.
- What could go wrong
- This is a small pilot study, not a large definitive trial. It may not provide clear answers, and stopping blood thinners could increase the risk of stroke or new clots.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEFT VENTRICULAR THROMBUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
St Bartholomews Hospital
London, EC1A4BE, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.